OneMedNet Signs Mediplexus as its 11th Channel Partner, Expanding the Company’s Real World Data Footprint into Korea and the Asia Pacific Region
OneMedNet (ONMD) signed a channel partner agreement with Mediplexus, expanding its real-world data (RWD) footprint into Korea and the Asia Pacific region. Mediplexus, a subsidiary of C&R Research, will distribute OneMedNet's U.S.-sourced RWD. The global RWE solutions market is projected to grow from $5.4B in 2025 to $10.8B by 2030, with Asia Pacific expected to lead growth.
How this was made
The 30-second read
Why it matters
The deal signals OneMedNet's strategic push into APAC, potentially increasing its addressable market and attracting investors seeking exposure to health‑data analytics.
Market read
First‑time announcement of a new channel partnership that could broaden OneMedNet's revenue base in a high‑growth region.
What to watch
Potential regulatory hurdles in Korea and competition from established local data providers could temper growth.
Background
OneMedNet provides AI‑ready, regulatory‑grade real‑world data sourced directly from U.S. providers. Expanding distribution through Mediplexus aims to capture growing demand for RWD in Korean biotech and med‑tech firms.
Ticker impact
OneMedNet announced its 11th channel partner agreement with Mediplexus to distribute its U.S. real‑world data in Korea and the Asia‑Pacific region.
potential upward pressure as the market prices in expanded distribution and growth opportunities
First‑time disclosure of a new Asia‑Pacific channel partner; no prior coverage, indicating fresh, material information for a listed company.
Market effects
Strengthens the real‑world data and health‑tech sector by highlighting demand for first‑party RWD in Asia‑Pacific.
Adds to Korean and broader APAC biotech/medtech data‑service ecosystem, may benefit local CROs and AI developers.
Modest; primarily affects OneMedNet and its niche market.
Counterpoint
The partnership may not translate into immediate revenue if integration challenges arise, limiting short‑term price impact.
Key entities
- companyOneMedNet Corporation
US‑listed provider of first‑party real‑world data (ticker ONMD).
- companyMediplexus
Korean healthcare data firm and subsidiary of C&R Research, acting as distributor for OneMedNet's data.
